Denmark· DK-28103468703
Telzir
A fosamprenavir product containing fosamprenavircalcium, registered in Denmark by Viiv Healthcare BV. The same ATC class is registered in 8 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Fosamprenavir is registered in 8 of 19 countries.
Countries holding a registration under ATC J05AE07 (fosamprenavir), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 6 of them publish a price we can compare per daily dose
Fosamprenavir · ATC J05AE07
8 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Franceprice
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of fosamprenavir costs, country by country.
Normalised to the WHO defined daily dose (1.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Fosamprenavir · price per daily dose (1.4 g)
USD · FX 28 Sept 2026
- FR France$13.86
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- FOSAMPRENAVIRCALCIUM
- Manufacturer
- Viiv Healthcare BV
- Country
- Denmark (DK)
- ATC code
- J05AE07
- ATC class
- Fosamprenavir
- Defined daily dose
- 1.4 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28103468703
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
336 interactions on record for fosamprenavir.
Graded by severity as the source publishes them — 116 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fosamprenavir · interactions on record
336 records
- 116 severe
- 186 moderate
- 7 minor
- 25 info
Most severe, free to view
- CisaprideA03FA02severe
- NaloxegolA06AH03severe
- LoperamideA07DA03severe
- BudesonideA07EA06severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J05AE07
Fosamprenavir, as other registers publish it.
- United StatesFosamprenavir CalciumSun Pharmaceutical Industries, Inc.
- United StatesFosamprenavir CalciumSun Pharmaceutical Industries, Inc.
- United StatesFosamprenavir CalciumMylan Pharmaceuticals Inc.
- PolandTelzirViiV Healthcare BV
- FinlandTelzirViiV Healthcare BV
- FinlandTelzirParanova Oy
- FinlandTelzirViiV Healthcare BV
- PolandTelzirViiV Healthcare BV
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d13ba08d-6cf3-445b-a192-d123f799cf8a GET /v1/drugs/d13ba08d-6cf3-445b-a192-d123f799cf8a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "700 mg",
"auth_role": "MOD",
"dk_drugid": "28103468703",
"substance": "FOSAMPRENAVIRCALCIUM",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "38180"
}See everything about fosamprenavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.